Medication info
ARB-Xg 10/160 Milligrams

ARB-Xg 10/160 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
Bright yellow oval film-coated tablets
Packaging
28 tablets (14 tablets/PTP*2), 30 tablets/bottle
Approval status
Active

MFDS item code 201308548 · Approved 2013.07.31 · Insurance code 647803840

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medicine. However, switching directly to this medicine may be considered when blood pressure is not controlled with monotherapy using the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
Pediatric patients under 18 years of age: Use of this medicine is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

In patients with essential hypertension, when blood pressure control is insufficient with monotherapy of amlodipine or valsartan alone, this medication can help achieve better blood pressure control. This contributes to stable management of blood pressure, reducing the risk of complications and improving health.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medicine. However, switching directly to this medicine may be considered when blood pressure is not controlled with monotherapy using the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

Pediatric patients under 18 years of age: Use of this medicine is not recommended because its safety and efficacy have not been established.

Precautions

This medication can cause severe harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. People who are allergic to the ingredients in this medication or similar drugs, pregnant or breastfeeding women, patients with severe kidney or liver disease, and patients with specific heart conditions should not take this medication. Patients with sodium or fluid depletion must correct their condition before taking this medication. If symptoms of hypotension occur while taking this medication, appropriate measures should be taken immediately. Patients with high potassium levels should take caution when using this medication alongside potassium supplements or potassium-sparing diuretics, and blood potassium levels should be regularly monitored. Patients with renal vascular issues or those who have received a kidney transplant require careful monitoring by a physician as this medication may affect kidney function. If symptoms of angioedema, such as swelling of the face, lips, or tongue, occur while taking this medication, it should be stopped immediately and not resumed. Patients with heart failure or following myocardial infarction should have regular tests to consider the possibility of changes in kidney function and hypotension while taking this medication. This medication may interact with other antihypertensive medications or drugs, so it is essential to inform healthcare providers of any other medications being taken. Caution is advised while driving or operating machinery as dizziness or fatigue may occur. Elderly patients may be prescribed a dosage similar to that of regular adults, but adjustments may be needed based on their physical condition. Children under 18 years of age are not recommended for this medication as its safety and efficacy have not been adequately established. In cases of overdose, severe hypotension or cardiovascular abnormalities may occur, so it is vital to adhere to the prescribed dose and visit a medical institution immediately if abnormal symptoms arise. It is important to regularly check blood pressure, kidney function, and electrolyte levels while taking this medication to confirm any abnormalities.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional vertigo, sensory disturbances, lightheadedness, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, pruritus, arthralgia, lumbago, arthritis, muscle spasms, lethargy, pollakiuria, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, renal impairment, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, emotional changes, tremor, sensory loss, taste disturbances, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, phototoxic reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroirritability, sensory loss, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The recommended storage temperature is at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablets

Package unit

28 tablets (14 tablets/PTP*2), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.